News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Atlas Venture and Shire plc Enter Alliance to Invest in Innovative Early-Stage Rare Disease Therapies



12/15/2011 7:20:45 AM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Atlas Venture, an early-stage venture capital firm, today announced that it has entered into a multi-year collaboration with Shire Human Genetic Therapies (“Shire”) to explore investment opportunities in early-stage rare disease therapeutics.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES